The effect of a casein hydrolysate on ghrelin release was reduced in mucosal segments of the human fundus, whereas the effect of the broadly tuned bitter agonist denatonium benzoate was apparently selectively blunted by obesity in human small intestinal—but not in fundic— segments [73,74]. This evidence concerns the gene GHRL and Obesity.